Advancing health care

Professor Clayton Christensen

Professor Christensen holds a B.A. from Brigham
Young University and an M.Phil. in applied econometrics from Oxford University where he studied as a Rhodes Scholar. He received an MBA and a DBA from the Harvard Business School, where he is currently the Kim B. Clark Professor of Business Administration. He is regarded as one of the world’s top experts on innovation and growth.

Christensen founded a number of successful companies and organisations which use and apply this theories in various ways: Innosight, a consulting firm helping companies create new growth businesses; Rose Park Advisors, a firm that identifies and invests in disruptive companies; and Innosight Institute, a non-profit think tank whose mission is to apply his theories to vexing societal problems such as healthcare and education.

Professor Christensen is the best-selling author of eight books and more than a hundred articles, including the New York Times best-selling, How Will You Measure Your Life? He received the Global Business Book Award for The Innovator’s Dilemma and The Economist named it as one of the six most important books about business ever written. In 2011 in a poll of thousands of executives, consultants and business school professors, Christensen was named as the most influential business thinker in the world.

David Albury

Director, The Innovation Unit Ltd, Design and Development Director, Global Education Leaders' Programme

David Albury is an internationally respected independent consultant and policy adviser specialising in forming and implementing strategies for innovation and transformation in healthcare and other public services. Over the last two decades he has worked with Government departments and agencies, foundations, provider and commissioning organisations in the UK, Finland, Australia, US, Canada and Brazil. He was Principal Adviser in the UK Prime Minister’s Strategy Unit 2002-6, where he co-authored the influential report Innovation in the Public Sector. He was an adviser on innovation and futures to Lord Darzi and the Department of Health in their ‘next stage’ review of the NHS. He is a Board Director of The Innovation Unit Ltd, Design and Development Director of the Global Education Leaders’ Program (GELP), an Associate of the Institute for Government, and Visiting Professor in Innovation Studies at King’s College London.

Among his current health clients are: Health Workforce Australia, Guy’s and St Thomas’s Charity, UCL Partners, UK Department of Health, New Zealand Ministry of Health.

Jeremy Myerson

Director & Helen Hamlyn Chair of Design,
Helen Hamlyn Centre, Royal College of Art & Design

Jeremy Myerson is the Helen Hamlyn Professor of Design at the Royal College of Art, London. An author, academic and activist in design, he co-founded the Helen Hamlyn Centre for Design in 1999 and set up InnovationRCA, the College's network for business, in 2004. His interdisciplinary research spans healthcare, workplace and inclusive design and he was recently Principal Investigator on the DOME (Designing Out Medical Error) study with Imperial College London, funded by the EPSRC. He is an expert on design thinking and has written a number of books on design themes in relation to social, demographic and technological change.

Professor Richard Bohmer

International Visiting Fellow, The King’s Fund

Dr Sam Barrell

Chief Clinical Officer, South Devon and Torbay Clinical Commissioning Group

Sam Barrell’s style of leadership is driven by her aim to “just make it better for patients” and as Chief Clinical Officer for South Devon and Torbay Clinical Commissioning Group, she has put innovation at the heart of the organisation’s approach to achieving this. 
 
Sam is well known for driving change, and believes that the key to better healthcare is whole system integration. Through the strategic ‘JoinedUp’ Cabinet in South Devon, she is working with other leaders of health and social care to deliver seamless, no-barriers services for local patients. She engages with national debate on policy – including through social media - and is often invited to speak nationally on her results-driven approach.
 
A partner at Compass House Medical Centre in Brixham, Devon, Sam also has a background as academic tutor and honorary university fellow at Plymouth Peninsula Medical School. Since 2011 she has been responsible for leading the formation of the CCG, which was recently authorised with no conditions and highly commended for the strength of its distributed clinical leadership.

Harry Longman

Chief Executive, Patient Access

Harry Longman set up Patient Access in 2011 with the GP inventors of a disruptive innovation in primary care.  An engineer by background, he recognised the simplicity and power of the method, and went on to show that not only did it increase the capacity of GPs to see more patients sooner, it was linked to 20% lower visits to A&E. 

From an early career in aeroengines and metal bashing, he has always been interested in what works.  Applying a systems thinking approach in a wide range of industries, he has specialised in healthcare in recent years and it was while working in an NHS PCT that he discovered what became known as the Patient Access method.  He's never happier than when poring over a new set of data or out fellrunning.

Dr Steve Laitner

GP, Parkbury House St Albans and Clinical Director, Patient Access

Sue Hill OBE

Chief Scientific Officer, Department of Health

Professor Sue Hill is a respiratory scientist by background, working for most of her career in the NHS and academia at University Hospital Birmingham (and its predecessors) and Birmingham University. Sue was appointed as Chief Scientific Officer in 2002 and heads the 50,000-strong healthcare science workforce in the NHS and related organisations - embracing over 45 specialist  fields in science, technology, engineering and mathematics.  In addition, Sue is the National Director of the Audiology and Physiological Diagnostics programme, the joint National Clinical Director for Respiratory Disease and has responsibility for the UK Modernising Scientific Careers programme. She works across government, with the NHS and other stakeholders to deliver strategic change, introducing new and innovative ways of working supported by modernised education and training, improving the quality of diagnostic and clinical services. As part of her role as DH Science and Society champion she raises the importance of science and innovation and of bringing science in health to life for young people.

Dr Richard Barker OBE

Director, CASMI, Chair, South London Academic Health Science Network

Richard is a strategic advisor, speaker and author on healthcare and life sciences.

He is Director of the Centre for the Advancement of Sustainable Medical Innovation, a major European initiative aimed at transforming the R&D and regulatory processes in life sciences to bring advances more rapidly and affordably to patients.

His 25-year business career in healthcare has spanned biopharmaceuticals, diagnostics and medical informatics – both in the USA and Europe. Most recently he was Director General of the Association of the British Pharmaceutical Industry, member of the Executive Committee of EFPIA (the European industry association) and Council member of IFPMA (the international equivalent). 

As a co-founder of Life Sciences UK, member of the NHS Stakeholder Forum, vice-chair of the UK Clinical Trials Collaboration and in many other roles, he has advised successive UK governments on healthcare issues, especially those relating to developing, valuing and using new healthcare technologies.

He is also chairman of the South London Academic Health Science Network, accelerating innovation in this region of the NHS, and Chairman of Stem Cells for Safer Medicines, a public-private partnership developing stem cell technology for predicting the safety profile of new medicines. He is a board member of Celgene, a major US-based bio-therapeutics company and of iCo Therapeutics, a Canadian bioscience company.

His past leadership roles include head of McKinsey’s European healthcare practice, General Manager of Healthcare Solutions for IBM and Chief Executive of Chiron Diagnostics.

He was also Chairman and Chief Executive of Molecular Staging, a US bioscience company, now part of Qiagen. He therefore has experience in leading and advising a wide range of high-technology companies.

His book on the future of healthcare 2030 - The Future of Medicine: Avoiding a Medical Meltdown is published by Oxford University Press. He speaks frequently on the future of life sciences and the restructuring of healthcare systems that new technology can enable.

He lives in London, but maintains an active business network in North America and worldwide.

Dr Yi Mien Koh

Chief Executive, Whittington Health

Dr Yi Mien Koh is Chief Executive of Whittington Health.  Her previous roles included Chief Executive at Hillingdon PCT, Director of Public Health, Performance and Medical Director at North West London SHA, and Director of Public Health and Policy at Kensington & Chelsea and Westminster Health Authority. Yi Mien has worked for the Healthcare Commission, the Commission for Health Improvement, was an honorary consultant with the Health Protection Agency and a visiting professor in Leadership and Management at London School of Hygiene and Tropical Medicine.

Yi Mien studied medicine at Melbourne University and trained in paediatrics and public health in London. She has an MBA from City University Business School and a DBA from Cranfield University. She is a Fellow of the Faculty of Public Health and Chartered Institute of Personnel and Development.

Geoff Mulgan

Chief Executive, NESTA

Geoff Mulgan is Chief Executive of Nesta (the UK’s National Endowment for Science Technology and the Arts).   Nesta combines investment in early stage companies, grant programmes in fields ranging from health and education to the arts and giving, and research.   From 2004-2011 Geoff was the first Chief Executive of the Young Foundation, which became a leading centre for social innovation, combining research, creation of new ventures and practical projects. 

Between 1997 and 2004 Geoff had various roles in the UK government including director of the Government's Strategy Unit and head of policy in the Prime Minister's office. Before that he was the founder and director of the think-tank Demos. He has also been Chief Adviser to Gordon Brown MP; a lecturer in telecommunications; an investment executive; and a reporter on BBC TV and radio. He is a visiting professor at LSE, UCL, Melbourne University and a regular lecturer at the China Executive Leadership Academy. He is an adviser to many governments around the world, and has been a board member of the Work Foundation, the Health Innovation Council, Political Quarterly and the Design Council, and chair of Involve.   He is currently Chair of the Studio Schools Trust and the Social Innovation Exchange.